Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial

By afschroeder • March 26, 2026

Hainstock MR, Fleming G, Kim D, Aboulhosn J, Levi D, Krasuski R, Sommer R, Torres AJ, Gray R, Kereiakes D, Leventhal A, Gillespie M, Szeto W, Zajarias A, Shahanavaz S, Steinberg ZL, Jones TK, Mahadevan VS, Moore P, Elmariah S, Shirali G, Li W, Babaliaros V, Lim DS; COMPASSION 3 Trial Executive Committee and Study Investigators. Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial. Circ Cardiovasc Interv. 2026 Mar 26:e016361. doi: 10.1161/CIRCINTERVENTIONS.125.016361. Epub ahead of print. PMID: 41884901.

Tags: Cardiology/Epi, endocarditis, Hemodynamics, Publications, pulmonary valve insufficiency, pulmonary valve stenosis, stents

A Polypill Strategy to Close the Heart Failure Treatment Gap

Fonarow GC, McMurray JJV. A Polypill Strategy to Close the Heart Failure Treatment Gap. JAMA Cardiol. 2026 Sep 30. doi: 10.1001/jamacardio.2026.3727. Epub ahead of print.[...]

Cardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart Failure

Kittipibul V, Ayodele I, Fonarow GC, Alhanti B, Van Spall HGC, Pandey A, Lewsey SC, Greene SJ. Cardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart Failure.[...]

Protocol for quantification of AAV-CRISPR-mediated hepatic gene editing in mice

Jarrett KE, Baltazar-Nunez R, Borja CA, Calderon PJ, Lai RW, Cheng A, Paudel M, Rubert GE, Suberski A, Traina OK, Cai SY, Srikanth K, Lagor[...]